cmi_logo.png
[Latest] Global Industrial Protective Clothing Market Size/Share Worth USD 20.63 Billion by 2032 at a 5.98% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
February 20, 2024 15:00 ET | Custom Market Insights
Austin, TX, USA, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Industrial Protective Clothing Market Size, Trends and Insights By Product (Heat...
Benchmark_logo.jpg
The Benchmark Company Announces Upcoming Healthcare House Call VIRTUAL One-on-One Investor Conference
April 27, 2023 09:00 ET | The Benchmark Company
NEW YORK, April 27, 2023 (GLOBE NEWSWIRE) -- The Benchmark Company is pleased to announce our upcoming Healthcare House Call VIRTUAL One-on-One Investor Conference to be held Tuesday, May 23, 2023....
Social-Media_VIC_Announcment_2.png
VolitionRx Limited to Webcast Live at VirtualInvestorConferences.com March 9th
March 06, 2023 16:30 ET | Virtual Investor Conferences
HENDERSON, Nev., March 06, 2023 (GLOBE NEWSWIRE) -- VolitionRx Limited (NYSE AMERICAN: VNRX), a multi-national epigenetics company, today announced that Scott Powell, Vice President of Investor...
Benchmark_logo.jpg
The Benchmark Company Announces Upcoming Discovery One-on-One Investor Conference
November 10, 2022 12:24 ET | The Benchmark Company
NEW YORK, Nov. 10, 2022 (GLOBE NEWSWIRE) -- The Benchmark Company is pleased to announce its 11th Annual Discovery One-on-One Investor Conference to be held Thursday, December 1st, 2022 at the New...
ReportLinker logo.jpg
Colon Cancer Drugs Market Research Report by Therapy, Cancer Type, Distribution Channel, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19
October 27, 2022 14:15 ET | ReportLinker
New York, Oct. 27, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Colon Cancer Drugs Market Research Report by Therapy, Cancer Type, Distribution Channel, Region -...
Social-Media_VIC_Announcment_2.png
VolitionRx Limited to Webcast Live at VirtualInvestorConferences.com September 15th
September 12, 2022 08:35 ET | Virtual Investor Conferences
HENDERSON, Nev., Sept. 12, 2022 (GLOBE NEWSWIRE) -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company developing simple, easy to use, cost effective blood...
SalariusLogo2ColorNoTag.jpg
Salarius Pharmaceuticals and VolitionRx Enter into R&D Collaboration Agreement
August 02, 2022 08:30 ET | Salarius Pharmaceuticals, Inc.
HOUSTON, Aug. 02, 2022 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (NASDAQ: SLRX), a clinical-stage biopharmaceutical company developing therapies for patients with cancer in need of new...
TIP_link_300x300.jpg
Colorectal Cancer Market Revenue to Cross $24.07 Bn Globally, by 2028 Growing at 3.3% CAGR - Exclusive Report by The Insight Partners
July 25, 2022 09:30 ET | The Insight Partners
New York, July 25, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on "Colorectal Cancer Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Modality,...
ReportLinker logo.jpg
Anatomic Pathology Market Research Report by Services, Pr?duct, Appl?cati?n, End User, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19
April 21, 2022 09:02 ET | ReportLinker
New York, April 21, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Anatomic Pathology Market Research Report by Services, Pr?duct, Appl?cati?n, End User, Region -...
Benchmark_logo.jpg
The Benchmark Company Announces Its Upcoming 10th Annual One-on-One Discovery Conference
November 18, 2021 10:19 ET | The Benchmark Company
NEW YORK, Nov. 18, 2021 (GLOBE NEWSWIRE) -- The Benchmark Company, LLC, an institutionally focused sales, trading, and investment banking firm, proudly announces its upcoming 10th Annual One-on-One...